Log In
BCIQ
Print this Print this
 

VTP-43742

  Manage Alerts
Collapse Summary General Information
Company Allergan plc
DescriptionOral small molecule inhibitor of RAR-related orphan receptor C thymus-specific isoform (RORgamma2; RORgammaT)
Molecular Target RAR-related orphan receptor C thymus-specific isoform (RORgamma2) (RORgammaT)
Mechanism of ActionRAR-related orphan receptor (ROR) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$639.0M

$639.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/25/2016

$639.0M

$639.0M

0

Get a free BioCentury trial today